| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |